Cannabis Commission Unveils Proposed Leadership Changes
July 12, 2024
Commissioners acknowledge need for clarity on roles of chair, executive director
Commissioners acknowledge need for clarity on roles of chair, executive director
“The entire industry deserves an opportunity to be heard before any major changes in rules are made—particularly those that will benefit the largest businesses.”
In testimony to joint cannabis committee, IG Jeffrey Shapiro explains reasons for proposed agency takeover, lays out potential path to receivership through legislature
Letter from Institute of Cannabis Science to lawmakers notes: “Our findings … show that fraudulent and harmful products reach consumers in Massachusetts.”
“I really don’t have much respect for politicians. They just close their mind … and don’t open it and look into things.”
“Day-to-day operations need to be controlled and there needs to be clarity as to who is running the operation.” Shapiro will testify before joint cannabis committee on Tuesday.
Policing plans are in flux for the now-banned substances, while other products stay legal
The question on decriminalizing some psychedelics as a therapeutic option has flown under the radar
“We will start issuing licenses and it will be up to the retailer based on staffing, stock and other considerations as to which day they will begin sales.”
“It would turn Florida into San Francisco, or Chicago, or some of these places.”
